Annual EBIT
-$7.49 M
+$10.16 M+57.55%
31 December 2023
Summary:
Galmed Pharmaceuticals annual earnings before interest & taxes is currently -$7.49 million, with the most recent change of +$10.16 million (+57.55%) on 31 December 2023. During the last 3 years, it has risen by +$22.72 million (+75.20%). GLMD annual EBIT is now -138.83% below its all-time high of -$3.13 million.GLMD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$2.01 M
-$789.00 K-64.57%
30 September 2024
Summary:
Galmed Pharmaceuticals quarterly earnings before interest & taxes is currently -$2.01 million, with the most recent change of -$789.00 thousand (-64.57%) on 30 September 2024. Over the past year, it has dropped by -$543.00 thousand (-36.99%). GLMD quarterly EBIT is now -239.12% below its all-time high of -$593.00 thousand, reached on 31 March 2013.GLMD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$6.79 M
-$543.00 K-8.70%
30 September 2024
Summary:
Galmed Pharmaceuticals TTM earnings before interest & taxes is currently -$6.79 million, with the most recent change of -$543.00 thousand (-8.70%) on 30 September 2024. Over the past year, it has increased by +$1.00 million (+12.90%). GLMD TTM EBIT is now -1044.18% below its all-time high of -$593.00 thousand, reached on 31 March 2013.GLMD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLMD EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.5% | -37.0% | +12.9% |
| 3 y3 years | +75.2% | +74.4% | +81.0% |
| 5 y5 years | +30.1% | +59.8% | +62.2% |
GLMD EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +77.2% | -64.6% | +74.4% | -8.7% | +81.0% |
| 5 y | 5 years | at high | +77.2% | -64.6% | +80.6% | -8.7% | +81.0% |
| alltime | all time | -138.8% | +77.2% | -239.1% | +83.7% | -1044.2% | +81.0% |
Galmed Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.01 M(+64.6%) | -$6.79 M(+8.7%) |
| June 2024 | - | -$1.22 M(-12.8%) | -$6.24 M(-9.4%) |
| Mar 2024 | - | -$1.40 M(-34.9%) | -$6.89 M(-8.0%) |
| Dec 2023 | -$7.49 M(-57.6%) | -$2.15 M(+46.5%) | -$7.49 M(-3.8%) |
| Sept 2023 | - | -$1.47 M(-21.5%) | -$7.79 M(-33.4%) |
| June 2023 | - | -$1.87 M(-6.5%) | -$11.70 M(-13.7%) |
| Mar 2023 | - | -$2.00 M(-18.3%) | -$13.56 M(-23.2%) |
| Dec 2022 | -$17.65 M(-46.3%) | -$2.45 M(-54.5%) | -$17.65 M(-22.2%) |
| Sept 2022 | - | -$5.38 M(+44.2%) | -$22.69 M(-9.8%) |
| June 2022 | - | -$3.73 M(-38.8%) | -$25.16 M(-15.7%) |
| Mar 2022 | - | -$6.09 M(-18.7%) | -$29.84 M(-9.2%) |
| Dec 2021 | -$32.88 M(+8.8%) | -$7.49 M(-4.5%) | -$32.88 M(-8.0%) |
| Sept 2021 | - | -$7.84 M(-6.7%) | -$35.73 M(+0.7%) |
| June 2021 | - | -$8.41 M(-7.9%) | -$35.48 M(+7.9%) |
| Mar 2021 | - | -$9.13 M(-11.7%) | -$32.88 M(+8.8%) |
| Dec 2020 | -$30.21 M(+35.0%) | -$10.34 M(+36.3%) | -$30.21 M(+6.0%) |
| Sept 2020 | - | -$7.59 M(+30.5%) | -$28.50 M(+10.0%) |
| June 2020 | - | -$5.82 M(-10.0%) | -$25.91 M(+4.5%) |
| Mar 2020 | - | -$6.46 M(-25.1%) | -$24.80 M(+10.8%) |
| Dec 2019 | -$22.38 M(+108.8%) | -$8.63 M(+72.3%) | -$22.38 M(+24.7%) |
| Sept 2019 | - | -$5.01 M(+6.5%) | -$17.95 M(+27.1%) |
| June 2019 | - | -$4.70 M(+16.4%) | -$14.12 M(+15.8%) |
| Mar 2019 | - | -$4.04 M(-3.8%) | -$12.20 M(+13.8%) |
| Dec 2018 | -$10.71 M | -$4.20 M(+256.0%) | -$10.71 M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$1.18 M(-57.5%) | -$10.16 M(-13.4%) |
| June 2018 | - | -$2.77 M(+8.4%) | -$11.73 M(+0.6%) |
| Mar 2018 | - | -$2.56 M(-29.8%) | -$11.66 M(-5.7%) |
| Dec 2017 | -$12.36 M(-26.8%) | -$3.64 M(+32.3%) | -$12.36 M(-8.2%) |
| Sept 2017 | - | -$2.75 M(+2.0%) | -$13.47 M(-7.2%) |
| June 2017 | - | -$2.70 M(-17.2%) | -$14.52 M(-9.5%) |
| Mar 2017 | - | -$3.26 M(-31.3%) | -$16.04 M(-5.0%) |
| Dec 2016 | -$16.88 M(+55.2%) | -$4.75 M(+24.9%) | -$16.88 M(+9.1%) |
| Sept 2016 | - | -$3.81 M(-9.9%) | -$15.47 M(+9.2%) |
| June 2016 | - | -$4.22 M(+2.9%) | -$14.17 M(+13.6%) |
| Mar 2016 | - | -$4.10 M(+22.7%) | -$12.47 M(+14.7%) |
| Dec 2015 | -$10.88 M(+19.0%) | -$3.35 M(+34.0%) | -$10.88 M(+13.5%) |
| Sept 2015 | - | -$2.50 M(-1.3%) | -$9.58 M(-6.7%) |
| June 2015 | - | -$2.53 M(+1.0%) | -$10.28 M(+8.1%) |
| Mar 2015 | - | -$2.50 M(+21.9%) | -$9.51 M(+4.0%) |
| Dec 2014 | -$9.14 M(-37.2%) | -$2.05 M(-35.6%) | -$9.14 M(-53.0%) |
| Sept 2014 | - | -$3.19 M(+80.9%) | -$19.44 M(+14.9%) |
| June 2014 | - | -$1.76 M(-17.4%) | -$16.92 M(+5.1%) |
| Mar 2014 | - | -$2.13 M(-82.7%) | -$16.10 M(+10.6%) |
| Dec 2013 | -$14.56 M(+364.2%) | -$12.36 M(+1758.0%) | -$14.56 M(+560.1%) |
| Sept 2013 | - | -$665.00 K(-29.9%) | -$2.21 M(+43.2%) |
| June 2013 | - | -$948.00 K(+59.9%) | -$1.54 M(+159.9%) |
| Mar 2013 | - | -$593.00 K | -$593.00 K |
| Dec 2012 | -$3.14 M | - | - |
FAQ
- What is Galmed Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual EBIT year-on-year change?
- What is Galmed Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly EBIT year-on-year change?
- What is Galmed Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals TTM EBIT year-on-year change?
What is Galmed Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of GLMD is -$7.49 M
What is the all time high annual EBIT for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual earnings before interest & taxes is -$3.13 M
What is Galmed Pharmaceuticals annual EBIT year-on-year change?
Over the past year, GLMD annual earnings before interest & taxes has changed by +$10.16 M (+57.55%)
What is Galmed Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of GLMD is -$2.01 M
What is the all time high quarterly EBIT for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$593.00 K
What is Galmed Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, GLMD quarterly earnings before interest & taxes has changed by -$543.00 K (-36.99%)
What is Galmed Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of GLMD is -$6.79 M
What is the all time high TTM EBIT for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high TTM earnings before interest & taxes is -$593.00 K
What is Galmed Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, GLMD TTM earnings before interest & taxes has changed by +$1.00 M (+12.90%)